Early Ga-68 FAPI PET/MR After Acute Myocardial Infarction

Acute myocardial infarction (AMI) initiates a complex myocardial repair process involving inflammation, fibroblast activation, and extracellular matrix remodeling, which may ultimately lead to adverse left ventricular remodeling and impaired cardiac function. Fibroblast activation protein (FAP)-targeted positron emission tomography (PET) enables noninvasive visualization of activated fibroblasts and may provide an early imaging biomarker of myocardial remodeling. This prospective single-center observational study aims to evaluate myocardial fibroblast activation using Ga-68 FAPI PET/MR performed approximately 10 ± 2 days after AMI and to investigate its association with subsequent left ventricular remodeling. Serial cardiac magnetic resonance (CMR) examinations will be performed at 3 and 6 months to assess changes in ventricular function and remodeling. The study will investigate whether early myocardial FAPI uptake is associated with subsequent structural and functional changes detected by CMR and evaluate the potential role of Ga-68 FAPI PET/MR as an imaging biomarker for post-infarction remodeling.

NCT Number	NCT07684924
Lead Sponsor	Ankara University
Conditions	Acute Myocardial Infarction (AMI)
Enrollment	25 participants
Start Date	2026-07-01
Primary Completion	2028-06-29 (estimated)
Study Completion	2028-06-29 (estimated)
Updated on ClinicalTrials.gov	2026-07-27